Story · Medicine & Biotech · Mind & Brain
Author Correction: In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial
1 outlet · first reported by Nature Medicine 9d ago
Coverage, in order
-
9d agoAuthor Correction: In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial
Nature Medicine, Published online: 03 November 2026; doi:10.1038/s41591-026-04786-9 Author Correction: In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.